NEUROSCIENTIFIC BIOPHARMACEUTICALS LIMITED

Otros idiomas NeuroScientific Biopharmaceuticals Limited

Acciones

NSB

AU0000012973

Diferido Australian S.E. Otros sitios de cotización 02:40:36 02/07/2024			Varia. Cinco días.	Varia. 1 de enero.
0,039 ^AUD	-2,50 %		+8,33 %	-11,36 %

11/06	Neuroscientific Biopharmaceuticals obtiene la aprobación de la FDA estadounidense para su medicamento contra el glaucoma	MT
20/03	NeuroScientific Biopharmaceuticals se asegura una rebaja fiscal de 2 millones de dólares australianos en I+D para el año fiscal 2023; las acciones suben un 6%.	MT

Otros idiomas

Desbloquee todas las noticias: ¡Sea el primero en enterarse y reaccione antes que los mercados!

Inscripción 100% Gratuita

Neuroscientific Biopharmaceuticals Secures US FDA Guidance for Glaucoma Medication	11/06
NeuroScientific Biopharmaceuticals Secures AU$2 Million R&D Tax Rebate for Fiscal Year 2023; Shares Rise 6%	20/03
NeuroScientific Biopharmaceuticals Limited Reports Earnings Results for the Half Year Ended December 31, 2023	27/02
NeuroScientific Biopharmaceuticals Limited Announces Changes to Board of Directors	05/12
NeuroScientific Biopharmaceuticals CEO to Step Down	01/12
NeuroScientific Biopharmaceuticals Limited Announces Resignation of Stephen Carter as CEO Effective 31 December 2023	01/12
Linda Friedland Steps Down from the Board of NeuroScientific Biopharmaceuticals Limited, Effective 17 November 2023	16/11
Neuroscientific Biopharmaceuticals Limited Announces Board Changes	12/11
NeuroScientific Biopharmaceuticals Ltd Appoints Linda Friedland as Independent Non-Executive Director	18/10/23
Neuroscientific Biopharmaceuticals Limited Announces Chief Executive Officer Changes	31/08/23
NeuroScientific Biopharmaceuticals Limited Reports Earnings Results for the Full Year Ended June 30, 2023	25/08/23
Neuroscientific Biopharmaceuticals Announce Positive Treatment Effect in Multiple sclerosis Animal Study	14/03/23
NeuroScientific Biopharmaceuticals Limited Reports Earnings Results for the Half Year Ended December 31, 2022	27/02/23
Neuroscientific Biopharmaceuticals Files New Patent for Multiple Sclerosis Treatment; Shares Jump 7%	05/12/22
NeuroScientific Biopharmaceuticals Files A New Patent, Entitled "Neuroprotective Compositions and Methods"	04/12/22
NeuroScientific Biopharmaceuticals Names Interim CEO; Shares Climb 12%	23/11/22
NeuroScientific Biopharmaceuticals Limited Announces Appointment of Mr. Paul Rennie as Interim CEO	22/11/22
NeuroScientific Biopharmaceuticals Limited Announces Management Changes	15/11/22
NeuroScientific Biopharmaceuticals Ltd Announces Resignation of Matt Liddelow as Managing Director	09/09/22
NeuroScientific Biopharmaceuticals Ltd Announces Resignation of Matt Liddelow as CEO	09/09/22

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas NeuroScientific Biopharmaceuticals Limited

Acciones

NSB

AU0000012973

Otros idiomas

Filtros